Skip to main content
Prognostic Value of Ambulatory Blood Pressure Load in Pediatric CKD.
Burosumab Therapy for X-Linked Hypophosphatemia and Therapeutic Implications for CKD.
Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis.
Time-Centered Approach to Understanding Risk Factors for the Progression of CKD.
Twenty-Four-Hour Ambulatory Blood Pressure versus Clinic Blood Pressure Measurements and Risk of Adverse Outcomes in Children with CKD.
FGF23 and Left Ventricular Hypertrophy in Children with CKD.
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
Height at First RRT and Mortality in Children.
Disordered FGF23 and mineral metabolism in children with CKD.
Regional variation in the incidence of dialysis-requiring AKI in the United States.